ENANTIOMERIC SPECIFICITY OF CARBOVIR TRANSPORT (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


ENANTIOMERIC SPECIFICITY OF CARBOVIR TRANSPORT (MEETING ABSTRACT)

Proc Annu Meet Am Assoc Cancer Res; 33:A112 1992. Unique Identifier : AIDSLINE ICDB/92682646
Domin BA; Mahony WB; Daluge SM; Miller WH; Zimmerman TP; Div. of Experimental Therapy, Wellcome Res. Laboratories,; Research Triangle Park, NC 27709


Abstract: Carbovir (CBV), a guanosine analog with a carbocyclic sugar, inhibits the replication of human immunodeficiency virus. The transport of CBV enantiomers into human erythrocytes at 37 C was examined with a 'papaverine-stop' assay. The influx of both (-)CBV and (+)CBV occurred primarily (greater than 60%) via the nucleobase transporter with Vmax (pmol/sec/5 ul cells)/Km (mM) values of 17/0.12 and 150/1.9, respectively. The Km for each enantiomer was similar to its Ki as a competitive inhibitor of acyclovir influx via the nucleobase carrier. (-)CBV and (+)CBV also entered these cells via the nucleoside transporter. Although the affinities of both enantiomers for this carrier were similar (Km = 2 mM), the Vmax for (-)CBV was much higher than that for (+)CBV. We conclude that (1) (-)CBV and (+)CBV enter human erythrocytes primarily by the nucleobase carrier and secondarily by the nucleoside carrier and (2) these two carriers show different enantiomeric specificities for CBV.
Keywords: Acyclovir/BLOOD Antiviral Agents/*BLOOD Binding, Competitive Biological Transport Blood Proteins/METABOLISM Carrier Proteins/*METABOLISM Dideoxynucleosides/*BLOOD/PHARMACOLOGY Erythrocytes/*METABOLISM Human Kinetics Membrane Proteins/*METABOLISM Stereoisomers ABSTRACTKWDacyclovir/bloodantiviralagents/KWDbloodbinding,competitivebiologicaltransportbloodproteins/metabolismcarrierproteins/KWDmetabolismdideoxynucleosides/KWDblood/pharmacologyerythrocytes/KWDmetabolismhumankineticsmembraneproteins/KWDmetabolismstereoisomersabstract
920730
M9271109

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .